Delivery Order SPE2DB20D1047-SPE2DB25FF36B
Award Date
1/10/25
Potential Completion Date
1/13/25
Potential Value
$6.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB24D2102|SPE2DB25FJHQE, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product, with a ceiling value of $1,329.55 and a completion date of December 10, 2024. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a ceiling value of $2,644.08 and an ultimate completion date of July 1, 2024. This appears to be a delivery order contract, priced on a firm fixed price basis. The contract is not designated with any set-aside requirements, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,052.50, is for the delivery of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product. This is a firm fixed-price delivery order contract with a completion date of December 3, 2024. Amerisourcebergen, as the prime contractor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FY85D, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $21,565.50 and an ultimate completion date of November 4, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to...
This federal contract award is for the delivery of BOOSTRIX TDAP vaccine syringes (0.5 mL) to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $1,583.80, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed-price pricing type, and the ultimate completion date is April 16, 2024. The contract is not designated as a set-aside and was...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of BOOSTRIX TDAP vaccine syringes. The contract has a ceiling value of $1,610.85 and a completion date of September 11, 2024. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award. The contract provides for the supply of essential medical...
This federal contract award is a Delivery Order with a Firm Fixed Price pricing type awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a ceiling value of $4,431.41 and an ultimate completion date of April 4, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $2,439.45 and a completion date of July 20, 2023. The award is not designated under any set-aside program, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,506.64, is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 15, 2025. The contract was not set aside for any specific business category. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $1,277.15. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...